EGFR and glioblastoma: They cloned a construct including a CAR specific for EGFRvIII, a glioblastoma-specific tumor antigen, that upon activation leads to the local secretion of a bispecific T cell engager (BiTE) against EGFR, an antigen frequently overexpressed in glioblastoma, but also expressed in normal tissues.